BiotechTube
Home/Orphina Biotechnology/Daniel Darvish, MD
DD

Daniel Darvish, MD

Founder

Orphina Biotechnology

Therapeutic Areas

OncologyRare DiseaseNeuromuscular

Orphina Biotechnology Pipeline

DrugIndicationPhase
H001GNE Myopathy (GNEM)Pre-clinical
H001nGNE Myopathy (GNEM)Discovery
H002GNE Myopathy (GNEM)Discovery